Literature DB >> 15147330

Low-grade systemic inflammation impairs arterial stiffness in newly diagnosed hypercholesterolaemia.

M Pirro1, G Schillaci, G Savarese, F Gemelli, G Vaudo, D Siepi, F Bagaglia, E Mannarino.   

Abstract

BACKGROUND: Excess of cardiovascular risk among patients with chronic inflammatory diseases has been attributed to increased arterial stiffness. Hypercholesterolaemia has been demonstrated to promote a low-grade inflammatory status. The objective of the present study was to define, in hypercholesterolaemia, the influence of plasma lipids, low-grade inflammation, and indices of adiposity on aortic pulse wave velocity, a measure of arterial stiffness and cardiovascular risk.
MATERIALS AND METHODS: Anthropometric characteristics, plasma lipids, C-reactive protein and aortic pulse wave velocity were measured in 85 subjects (60 patients with newly diagnosed never-treated hypercholesterolaemia and 25 age- and sex-matched normocholesterolaemic controls).
RESULTS: Plasma C-reactive protein and aortic pulse wave velocity were significantly higher among hypercholesterolaemic patients than in controls (P < 0.05 for both). Aortic pulse wave velocity was associated with age (r = 0.24, P = 0.04), body mass index (r = 0.33, P = 0.006), waist (r = 0.42, P < 0.001) and hip (r = 0.32, P = 0.007) circumferences, as well as with systolic (r = 0.34, P = 0.003) and diastolic (r = 0.30, P = 0.01) blood pressures, plasma C-reactive protein (r = 0.51, P < 0.001), total cholesterol (r = 0.45, P < 0.001), and low-density lipoprotein cholesterol (r = 0.46, P < 0.001). In the multivariate analysis, waist circumference and C-reactive protein levels predicted increased aortic stiffness, independently of traditional cardiovascular risk factors. The degree of independent association between cholesterol, systolic blood pressure and aortic stiffness increased when indices of adiposity and inflammation were excluded from the multivariate analysis. Comparable results were obtained when the analyses were restricted to hypercholesterolaemic patients.
CONCLUSIONS: Low-grade systemic inflammation and abdominal fat, more than traditional risk factors, are major determinants of reduced arterial distensibility in hypercholesterolaemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147330     DOI: 10.1111/j.1365-2362.2004.01345.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  14 in total

1.  Stress transesophageal echocardiography to simultaneously detect coronary and aortic vascular dysfunction in hypercholesterolemia: image two birds with one stone?

Authors:  B J M Mulder; E E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2007-02       Impact factor: 2.357

2.  Aortic perivascular adipose-derived interleukin-6 contributes to arterial stiffness in low-density lipoprotein receptor deficient mice.

Authors:  Bing Du; An Ouyang; Jason S Eng; Bradley S Fleenor
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-03       Impact factor: 4.733

3.  Effects of 5 % weight loss through diet or diet plus exercise on cardiovascular parameters of obese: a randomized clinical trial.

Authors:  Ana Paula Trussardi Fayh; André Luiz Lopes; Antônio Marcos Vargas da Silva; Alvaro Reischak-Oliveira; Rogério Friedman
Journal:  Eur J Nutr       Date:  2012-10-07       Impact factor: 5.614

4.  Impaired coronary flow velocity reserve and aortic distensibility in patients with untreated hypercholesterolemia--an echocardiographic study.

Authors:  Attila Nemes; Tamás Forster; Miklós Csanády
Journal:  Int J Cardiovasc Imaging       Date:  2006-06-16       Impact factor: 2.357

5.  Molecular biology of atherosclerosis.

Authors:  Elmo Mannarino; Matteo Pirro
Journal:  Clin Cases Miner Bone Metab       Date:  2008-01

6.  Thyroid-Stimulating Hormone Predicts Total Cholesterol and Low-Density Lipoprotein Cholesterol Reduction during the Acute Phase of COVID-19.

Authors:  Massimo Raffaele Mannarino; Vanessa Bianconi; Elena Cosentini; Filippo Figorilli; Cecilia Colangelo; Francesco Giglioni; Rita Lombardini; Rita Paltriccia; Matteo Pirro
Journal:  J Clin Med       Date:  2022-06-10       Impact factor: 4.964

7.  Impact of chronic anticholesterol therapy on development of microvascular rarefaction in the metabolic syndrome.

Authors:  Adam G Goodwill; Stephanie J Frisbee; Phoebe A Stapleton; Milinda E James; Jefferson C Frisbee
Journal:  Microcirculation       Date:  2009-11       Impact factor: 2.628

8.  Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection.

Authors:  Renate Schnabel; Martin G Larson; Josée Dupuis; Kathryn L Lunetta; Izabella Lipinska; James B Meigs; Xiaoyan Yin; Jian Rong; Joseph A Vita; Christopher Newton-Cheh; Daniel Levy; John F Keaney; Ramachandran S Vasan; Gary F Mitchell; Emelia J Benjamin
Journal:  Hypertension       Date:  2008-04-21       Impact factor: 10.190

9.  High Sensitivity C - Reactive Protein is Associated with Diastolic Dysfunction in Young African Americans without Clinically Evident Cardiac Disease.

Authors:  Venkataraman Rajaram; Arthur T Evans; Gloria C Caldito; Russell F Kelly; Leon Fogelfeld; Henry R Black; Rami Doukky
Journal:  Open Cardiovasc Med J       Date:  2011-08-22

Review 10.  Circulatory syndrome: an evolution of the metabolic syndrome concept!

Authors:  Ali Reza Khoshdel; Shane L Carney; Alastair Gillies
Journal:  Curr Cardiol Rev       Date:  2012-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.